Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qualipride International is a China-based private company specializing in the extraction and purification of stevia. It has developed proprietary technology for producing high-purity rebaudioside A ("Reb A") and other steviol glycosides from Stevia leaf. The company supplies major multinational ingredient companies and wholesalers globally, exporting hundreds of tons annually. In 2014, it entered into an exclusive partnership with Stevia First Corp. to license its technology outside China and transfer its sales/distribution business to SF Pure—a subsidiary managed jointly by both parties. Through this partnership, Qualipride's expertise underpins new North American production facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qualipride.